Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.413
H.R.413: To eliminate the 2-year delay in including oral-only ESRD-related drugs in the Medicare ESRD prospective payment system, as provided under section 632(b)(1) of the American Taxpayer Relief Act of 2012.
About This Bill
- This bill was introduced in the 113th Congress
- This bill is primarily about health
- Introduced Jan. 23, 2013
- Latest Major Action Feb. 8, 2013
Bill Sponsor
Bill Cosponsors
3 (2 Democrats, 1 Republican)
Bill Summary
Amends the American Taxpayer Relief Act of 2012 to eliminate the two-year delay (until January 1, 2016) of the authority of the Secretary of Health and Human Services (HHS) to implement oral-only End Stage Renal Disease (ESRD)-related drugs in the ESRD prospective payment system (PPS) under title XVIII (Medicare) of the Social Security Act. (Thus authorizes the Secretary to implement such drugs in the ESRD-PPS immediately.)
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Feb. 8, 2013 |
Referred to the Subcommittee on Health.
|
Jan. 25, 2013 |
Referred to the Subcommittee on Health.
|
Jan. 23, 2013 |
Referred to House Ways and Means
|
Jan. 23, 2013 |
Referred to House Energy and Commerce
|
Jan. 23, 2013 |
Introduced in the House by Peter Welch (D-Vt.) |